Current and Future Treatment Options for Nonexudative and Exudative Age-Related Macular Degeneration
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 21 (15) , 967-992
- https://doi.org/10.2165/00002512-200421150-00002
Abstract
No abstract availableKeywords
This publication has 151 references indexed in Scilit:
- Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomesOphthalmology, 2003
- Relation of Statin Use to the 5-Year Incidence and Progression of Age-Related MaculopathyArchives of Ophthalmology (1950), 2003
- Progression of Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2003
- Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration11InternetAdvance publication at ajo.com. May 7, 2002.American Journal of Ophthalmology, 2002
- Strahlentherapie okkulter choroidaler NeoVaskularisationen (CNV) bei altersabhängiger Makuladegeneration (AMD)Klinische Monatsblätter für Augenheilkunde, 1999
- Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degenerationOphthalmology, 1998
- Clinical possibilities in retinal pigment epithelial transplantationsActa Ophthalmologica Scandinavica, 1997
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Dye enhanced laser photocoagulation in the treatment of a peripapillary subretinal neovascular membraneActa Ophthalmologica, 1994
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989